AstraZeneca asks the FDA to authorize first-ever preventative drug for COVID-19 after trials show the monoclonal antibody treatment reduced the risk of developing...

AstraZeneca has asked the FDA to authorize a new treatment which reduces risk of developing symptomatic COVID-19 by 77%. It uses lab-made antibodies to protect against Covid sympto…